JP3000224B2 - Skin cosmetics - Google Patents
Skin cosmeticsInfo
- Publication number
- JP3000224B2 JP3000224B2 JP2073993A JP7399390A JP3000224B2 JP 3000224 B2 JP3000224 B2 JP 3000224B2 JP 2073993 A JP2073993 A JP 2073993A JP 7399390 A JP7399390 A JP 7399390A JP 3000224 B2 JP3000224 B2 JP 3000224B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- mix
- effect
- ethyl alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 14
- 239000000284 extract Substances 0.000 claims description 15
- 210000003491 skin Anatomy 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 9
- 210000001732 sebaceous gland Anatomy 0.000 description 9
- 210000002374 sebum Anatomy 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000028327 secretion Effects 0.000 description 7
- 206010013786 Dry skin Diseases 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000699673 Mesocricetus auratus Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000219784 Sophora Species 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- -1 fatty acid ester Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical class COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000580 secretagogue effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は皮膚化粧料、更に詳細には皮脂分泌促進作用
を有し、肌荒れの改善、皮膚炎症の軽減及び肌の老化を
防止・改善する皮膚化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to skin cosmetics, and more particularly, has a sebum secretion promoting action, improves skin roughness, reduces skin inflammation, and prevents / improves skin aging. It relates to skin cosmetics.
皮脂はトリグリセライド、スクワレン及びワックスエ
ステルを主要構成成分とし、皮脂腺及び表皮細胞から分
泌されるものであり、皮膚や毛髪等の表面で膜を形成す
ることによって皮膚や毛髪組織を外部刺激等から保護す
るという重要な役割を果たしている。Sebum is mainly composed of triglyceride, squalene and wax ester, and is secreted from sebaceous glands and epidermal cells, and protects skin and hair tissue from external stimuli by forming a film on the surface of skin or hair. Plays an important role.
また、斯かる皮脂の分泌は年齢と共に減少することが
知られており、こうした皮脂の欠乏が肌荒れや乾皮症等
の大きな原因の一つと考えられている。更に、皮脂腺機
能が衰えてくると、同時に肌の美しい外観やなめらかな
感触も損なわれ、「つや」や「はり」を失った、いわゆ
る老化した肌を呈するようになる。Further, it is known that the secretion of such sebum decreases with age, and such a deficiency of sebum is considered to be one of the major causes of rough skin, xeroderma and the like. Further, when the sebaceous gland function deteriorates, the beautiful appearance and smooth feel of the skin are also impaired, and the so-called aging skin which has lost its "luster" and "stick" comes to appear.
そこで肌荒れ等を防止、改善するためには、皮脂分泌
促進作用を有する成分を化粧料等を配合することが有用
な手段と考えられ、様々な研究がなされてきたが、皮脂
分泌促進作用を有する物質としては、フェルラ酸エステ
ルの混合物であるγ−オリザノール〔小林敏夫,早川律
子,皮膚,21,123(1979)〕や、分岐型脂肪酸エステル
誘導体〔吉塚直伸,芋川玄爾,日皮会誌,94,411(198
4)〕などごくわずかなものしか見出されておらず、ま
た得られる効果も未だ充分満足のいくものではなかっ
た。Therefore, in order to prevent and improve rough skin etc., it is considered that it is a useful means to mix a component having a sebum secretion promoting action with cosmetics and the like, and various studies have been made, but it has a sebum secretion promoting action. Examples of the substance include γ-oryzanol, which is a mixture of ferulic acid esters [Toshio Kobayashi, Ritsuko Hayakawa, Dermatology, 21 , 123 (1979)], and branched fatty acid ester derivatives [Naoshinobu Yoshizuka, Genji Imokawa, Journal of Nisshinkai, 94 , 411 (198
4)], etc., and very few effects have been found, and the obtained effects have not been sufficiently satisfactory.
斯かる実情に鑑み、本発明者らは皮脂分泌促進という
観点から種々検討した結果、槐花、決明子及び金桜子か
ら選ばれる生薬の抽出物が顕著な皮脂分泌促進作用を有
していることを見出し、本発明を完成した。In view of such circumstances, the present inventors have conducted various studies from the viewpoint of promoting sebum secretion, and found that an extract of a crude drug selected from Sophora oleracea, Akiko and Kinsakurako has a remarkable sebum secretion promoting action. Heading, the present invention has been completed.
すなわち、本発明は決明子の抽出物を含有することを
特徴とする皮膚化粧料を提供するものである。That is, the present invention provides a skin cosmetic comprising an extract of Sadako.
本発明に用いられる槐花、決明子及び金桜子から得ら
れる生薬抽出物の調製法は特に限定されないが、例えば
種々の適当な溶媒を用いて室温〜加温下で抽出される。
抽出溶媒としては、例えば、水;メチルアルコール、エ
チルアルコール等の低級一価アルコール;グリセリン、
プロピレングリコール、1,3−ブチレングリコール等の
液状多価アルコール;酢酸エチル等の低級アルキルエス
テル;ベンゼン、ヘキサン等の炭化水素;ジエチルエー
テル等のエーテル類等の一種又は二種以上を用いること
ができる。就中、水又は水溶性溶媒、特に水、エチルア
ルコール、グリセリン、1,3−ブチレングリコールの一
種又は二種以上の混合溶媒が好ましい。また抽出条件と
しては、生薬に対し容量比で1〜1000倍量、特に5〜10
0倍量の溶媒を用い、4℃以上、特に15〜30℃の温度で
1時間以上、特に1〜3日間行うのが好ましい。The method of preparing the crude drug extract obtained from Sophoraceae, Kaeriko and Sakurako used in the present invention is not particularly limited. For example, the crude drug extract is extracted at room temperature to under heating using various suitable solvents.
Examples of the extraction solvent include water; lower alcohols such as methyl alcohol and ethyl alcohol; glycerin,
Liquid polyhydric alcohols such as propylene glycol and 1,3-butylene glycol; lower alkyl esters such as ethyl acetate; hydrocarbons such as benzene and hexane; and one or more kinds of ethers such as diethyl ether can be used. . Among them, water or a water-soluble solvent, particularly one of water, ethyl alcohol, glycerin and 1,3-butylene glycol, or a mixed solvent of two or more thereof is preferred. The extraction conditions are 1 to 1000 times the volume of the crude drug, especially 5 to 10 times.
It is preferable to carry out the reaction at a temperature of 4 ° C. or more, particularly 15 to 30 ° C., for 1 hour or more, particularly 1 to 3 days, using 0 times the amount of solvent.
以上のような条件で得られる生薬抽出物は、抽出され
た溶液のまま用いてもよいが、さらに必要により濃縮、
濾過等の処理をしたものを適宜使い分けて用いることが
できる。The crude drug extract obtained under the above conditions may be used as it is in the extracted solution, but further concentrated if necessary.
Those that have been subjected to a treatment such as filtration can be appropriately used.
本発明の皮膚化粧料において、生薬抽出物は一種又二
種以上を配合することができ、その量は、乾燥固形分に
換算して合計で0.0001〜10.0重量%が好ましく、特に0.
01〜5.0重量%の範囲が好ましい。In the skin cosmetics of the present invention, one or more crude drug extracts can be blended, and the amount thereof is preferably 0.0001 to 10.0% by weight in total as converted to dry solids, and particularly preferably 0.1 to 0.1% by weight.
The range of 01 to 5.0% by weight is preferred.
また、本発明の皮膚化粧料には、必要により牛・人な
どの胎盤抽出物、牛・豚などの胸腺抽出物、牛・豚など
の脾臓抽出物、アデノシン三リン酸又はその塩、ビタミ
ンA類及びそれらの誘導体、ビタミンD類及びそれらの
誘導体、コハク酸及びそれらの誘導体及びそれらの塩、
アロエ抽出物、人参抽出物等の細胞賦活剤などを添加し
てもよい。The skin cosmetic composition of the present invention may further include a placenta extract such as cows and humans, a thymus extract such as cows and pigs, a spleen extract such as cows and pigs, adenosine triphosphate or a salt thereof, and vitamin A, if necessary. And their derivatives, vitamin D and their derivatives, succinic acid and their derivatives and their salts,
Cell activators such as aloe extract and ginseng extract may be added.
本発明の皮膚化粧料は、上記成分の他、通常化粧品、
医薬部外品に用いられる水性成分、粉体、界面活性剤、
油剤、保湿剤、アルコール、pH調整剤、防腐剤、酸化防
止剤、紫外線吸収剤、増粘剤、色素、香料、美容成分等
を必要に応じて適宜配合することにより調製される。Skin cosmetics of the present invention, in addition to the above components, usually cosmetics,
Aqueous components, powders, surfactants used in quasi-drugs,
It is prepared by appropriately mixing an oil agent, a humectant, an alcohol, a pH adjuster, a preservative, an antioxidant, an ultraviolet absorber, a thickener, a pigment, a fragrance, a cosmetic ingredient, and the like as needed.
本発明の皮膚化粧料の剤型は特に限定されず、化粧
水、乳液、クリーム、パック、洗浄料等種々の剤型とす
ることができる。The dosage form of the skin cosmetic of the present invention is not particularly limited, and various dosage forms such as a lotion, an emulsion, a cream, a pack, and a cleanser can be used.
以下に試験例及び実施例を挙げて本発明を更に説明す
る。Hereinafter, the present invention will be further described with reference to Test Examples and Examples.
試験例1 シリアンハムスターの耳介部皮脂腺を用いて、各被験
物質の皮脂腺に対する作用を検討した。Test Example 1 The effect of each test substance on the sebaceous glands was examined using ear sebaceous glands of Syrian hamsters.
槐花、決明子及び金桜子のそれぞれ10gに70%エチル
アルコール30mlを加え、時々攪拌しながら室温で2日間
浸漬した後、濾過して得られた生薬抽出物並びに5%γ
−オリザノールエチルアルコール溶液を被験物質とし
た。30 g of 70% ethyl alcohol was added to 10 g of each of Sophora Gosei, Akemiko and Sakurako, soaked at room temperature for 2 days with occasional stirring, and filtered to obtain a crude drug extract and 5% γ.
-Oryzanol ethyl alcohol solution was used as the test substance.
10周齢の雌のシリアンハムスターを1群6匹とし、そ
れぞれのシリアンハムスターの右側耳介部内側に、上述
の被験物質を0.05mlずつ毎日塗布した。また左側耳介部
内側には対照として70%エチルアルコール0.05mlを塗布
した。A group of 6 female Syrian hamsters of 10 weeks of age was applied to the inside of the right pinna of each Syrian hamster, and 0.05 ml of the above-described test substance was applied daily. Further, 0.05 ml of 70% ethyl alcohol was applied to the inside of the left pinna as a control.
塗布は10日間行い、11日目に左右の耳介を一定の大き
さに打ちぬき、表皮と軟骨を剥離して真皮シートを作成
した。該真皮シート顕微鏡下で20倍に拡大して写真を撮
影し、花弁状に観察される皮脂腺の最大径を10カ所測定
した。The application was performed for 10 days. On the eleventh day, the left and right auricles were punched out to a predetermined size, and the epidermis and cartilage were peeled off to prepare a dermis sheet. Under the dermis sheet microscope, a photograph was taken at a magnification of 20 times, and the maximum diameter of the sebaceous gland observed in a petal shape was measured at 10 places.
その結果、皮脂腺の大きさは下記第1表のようにな
り、被験物質塗布側はいずれも顕著に皮脂腺が拡大され
ており、比較として用いたγ−オリザノールよりも優れ
た皮脂腺賦活作用、すなわち皮脂分泌促進作用を示し
た。As a result, the size of the sebaceous gland was as shown in Table 1 below, and the sebaceous gland was remarkably enlarged on each of the test substance application sides, and the sebaceous gland activating action superior to γ-oryzanol used for comparison, ie, sebaceous gland A secretagogue was shown.
実施例1 化粧水: (組 成) (重量%) (1) グリセリン 8.0 (2) 1,3−ブチレングリコール 12.0 (3) エチルアルコール 5.0 (4) ポリオキシエチレンソルビタンモ ノラウリン酸エステル(20E.O.) 1.0 (5) ピロリドンカルボン酸ナトリウム 0.2 (6) 槐花1,3−ブチレングリコール抽出液*1 0.5 (7) ウロカニン酸 0.1 (8) ヒアルロン酸ナトリウム 0.02 (9) コラーゲン 0.1 (10) 防腐剤 適量 (11) 香 料 適量(12) 精製水 残量 計 100.0 *1 槐花抽出物を乾燥固形分として約9%含有した
もの。 Example 1 Lotion: (Composition) (% by weight) (1) Glycerin 8.0 (2) 1,3-butylene glycol 12.0 (3) Ethyl alcohol 5.0 (4) Polyoxyethylene sorbitan monolaurate (20E.O) .) 1.0 (5) Sodium pyrrolidonecarboxylate 0.2 (6) Sophora 1,3-butylene glycol extract * 1 0.5 (7) Urocanic acid 0.1 (8) Sodium hyaluronate 0.02 (9) Collagen 0.1 (10) Preservative Appropriate amount (11) Flavor Appropriate amount (12) Purified water Fuel gauge 100.0 * 1 Contains about 9% of Sophorae extract as dry solids.
(製 法) A.(3)、(4)、(10)、(11)を混合溶解とする。(Production method) A. Mix and dissolve (3), (4), (10) and (11).
B.(1)、(2)、(5)〜(9)及び(12)を混合溶
解する。B. Mix and dissolve (1), (2), (5) to (9) and (12).
C.AとBを混合して均一にする。C. Mix A and B to make uniform.
実施例2 クリーム: (組 成) (重量%) (1) ミツロウ 5.0 (2) セタノール 5.0 (3) 還元ラノリン 6.0 (4) スクワラン 42.0 (5) グリセリンモノステアレート 4.0 (6) コレステリルステアレート 0.5 (7) ビタミンEリノレート 0.1 (8) 親油型モノステアリン酸グリセリン 2.0 (9) ポリオキシエチレンソルビタンモ ノラウリン酸エステル(20E.O.) 2.0 (10) 決明子50%エチルアルコール抽出液*2 1.0 (11) デオキシリポ核酸ナトリウム 0.05 (12) 防腐剤 適量 (13) 香 料 適量 (14) 1,3−ブチレングリコール 5.0 (15) 精製水 残量 計 100.0 *2 決明子抽出物を乾燥固形分として約7%含有し
たもの。Example 2 Cream: (Composition) (% by weight) (1) Beeswax 5.0 (2) Cetanol 5.0 (3) Reduced lanolin 6.0 (4) Squalane 42.0 (5) Glycerin monostearate 4.0 (6) Cholesteryl stearate 0.5 ( 7) Vitamin E linoleate 0.1 (8) Lipophilic glyceryl monostearate 2.0 (9) Polyoxyethylene sorbitan monolaurate (20E.O.) 2.0 (10) Sekiko 50% ethyl alcohol extract * 2 1.0 (11) ) Sodium deoxyliponucleic acid 0.05 (12) Suitable amount of preservative (13) Suitable amount of fragrance (14) 1,3-butylene glycol 5.0 (15) Purified water Fuel gauge 100.0 * 2 Contains about 7% dry matter extract as dry solids What you did.
(製 法) A.(1)〜(9)及び(12)〜(14)を混合し、加熱し
て70℃に保つ。(Preparation method) A. Mix (1) to (9) and (12) to (14) and heat to 70 ° C.
B.(10)、(11)及び(15)を混合し、加熱して70℃に
保つ。B. Mix (10), (11) and (15) and heat to 70 ° C.
C.BにAを加えて均一に乳化し、30℃まで冷却する。C. Add A to B, emulsify uniformly, and cool to 30 ° C.
実施例3 乳液: (組 成) (重量%) (1) スクワラン 7.0 (2) ワセリン 0.7 (3) ミツロウ 0.3 (4) ソルビタンセスキオレイン酸エステル 0.8 (5) ポリオキシエチレンオレイルエーテル(20E.
O.) 1.5 (6) 1,3−ブチレングリコール 8.0 (7) 金桜子70%エチルアルコール抽出液*3 0.8 (8) ビタミンE 0.1 (9) 紫外線吸収剤 0.5 (10) プラセンタエキス 0.5 (11) グリチルリチン酸ジカリウム 0.02 (12) エチルアルコール 5.0 (13) 防腐剤 適量 (14) 香 料 適量(15) 精製水 残量 計 100.0 *3 金桜子抽出物を乾燥固形分として約7%含有し
たもの (製 法) A.(1)〜(9)及び(12)〜(14)を混合し、加熱し
て70℃に保つ。Example 3 Emulsion: (Composition) (% by weight) (1) Squalane 7.0 (2) Vaseline 0.7 (3) Beeswax 0.3 (4) Sorbitan sesquioleate 0.8 (5) Polyoxyethylene oleyl ether (20E.
O.) 1.5 (6) 1,3-butylene glycol 8.0 (7) Sakurako 70% ethyl alcohol extract * 3 0.8 (8) Vitamin E 0.1 (9) UV absorber 0.5 (10) Placenta extract 0.5 (11) Dipotassium glycyrrhizinate 0.02 (12) Ethyl alcohol 5.0 (13) Preservatives proper amount (14) Flavors proper amount (15) Purified water Remaining meter 100.0 * 3 Contains about 7% of dried cherry solid extract (manufactured by Method) A. Mix (1)-(9) and (12)-(14) and heat to 70 ° C.
B.(10)、(11)及び(15)を混合し、加熱して70℃に
保つ。B. Mix (10), (11) and (15) and heat to 70 ° C.
C.BにAを加えて均一に乳化し、30℃まで冷却する。C. Add A to B, emulsify uniformly, and cool to 30 ° C.
実施例4 パック: (組 成) (重量%) (1) ポリビニルアルコール 15.0 (2) カルボキシメチルセルロースナト リウム 5.0 (3) 1,3−ブチレングリコール 3.0 (4) 金桜子水抽出液*4 0.3 (5) エチルアルコール 10.0 (6) コウジ酸 1.0 (7) 防腐剤 適量 (8) 香 料 適量(9) 精製水 残量 計 100.0 *4 金桜子抽出物を乾燥固形分として約11%含有し
たもの (製法) A.(1)〜(4)、(6)及び(9)を混合し、70℃に
加熱し攪拌しなから溶解せしめる。Example 4 Pack: (Composition) (% by weight) (1) Polyvinyl alcohol 15.0 (2) Sodium carboxymethylcellulose 5.0 (3) 1,3-butylene glycol 3.0 (4) Gold extract aqueous extract * 4 0.3 (5) Ethyl alcohol 10.0 (6) Kojic acid 1.0 (7) Appropriate preservative (8) Appropriate flavor (9) Purified water Remaining meter 100.0 * 4 Contains about 11% dry cherry as a dry solid content (Production method) A. Mix (1) to (4), (6) and (9), heat to 70 ° C., and stir to dissolve.
B.(5)、(7)及び(8)を混合する。B. Mix (5), (7) and (8).
C.AにBを加えて混合した後冷却する。C. Add B to A, mix and cool.
試験例2 使用効果試験: 本発明の皮膚化粧料の肌荒れ改善効果及び老化防止効
果につき、使用テストにより試験を行った。Test Example 2 Use effect test: The use of the skin cosmetic of the present invention was tested for the effect of improving skin roughness and the effect of preventing aging by a use test.
使用テストは、それぞれ30〜50才の20名の女性をパネ
ルとし、毎日、朝と夜の2回、洗顔後に試験化粧料を適
量顔面に2週間にわたって塗布することにより行った。
試験化粧料は実施例1の化粧水、実施例3の乳液及び対
照として実施例3の乳液の(7)金桜子70%エタノール
抽出液を除いて精製水で補正した以外は実施例3と同様
に製造したものを用いた。結果を第2表に示す。The use test was carried out by applying a suitable amount of the test cosmetic to the face for two weeks after washing the face twice daily in the morning and at night, using 20 women aged 30 to 50 as panels.
The test cosmetics were the same as in Example 3 except that the lotion of Example 1, the emulsion of Example 3 and the emulsion of Example 3 as a control were corrected with purified water except for the (7) 70% ethanol extract of Kokurako. Was used. The results are shown in Table 2.
尚、評価は次の基準で行った。 The evaluation was performed according to the following criteria.
・肌荒れ改善効果 有 効:肌のかさつきや荒れが改善された。・ Skin roughness improvement effect Effective: Skin roughness and roughness were improved.
やや有効:肌のかさつきや荒れがやや改善された。 Slightly effective: Skin roughness and roughness were slightly improved.
無 効:変わらない。 Ineffective: No change.
・老化防止効果 有 効:小じわが目立たなくなり、肌につやが出
た。・ Anti-aging effect Effective: Wrinkles became inconspicuous and skin became shiny.
やや有効:小じわがやや目立たなくなった。 Slightly effective: Wrinkles are slightly less noticeable.
無 効:変わらない。 Ineffective: No change.
第2表の結果より明らかなように、実施例1の化粧水
及び実施例3の乳液の使用により、肌荒れが改善された
という効果及び小じわが目立たなくなったという効果が
高い有効率をもって確認された。 As is clear from the results shown in Table 2, the use of the lotion of Example 1 and the emulsion of Example 3 confirmed that the effect of improving skin roughness and the effect of making fine wrinkles less noticeable were at a high effective rate. .
〔発明の効果〕 本発明の皮膚化粧料は顕著な皮脂分泌促進作用を有す
るため、優れた肌荒れ改善効果、皮膚の炎症の軽減効果
等があり、幅広く適用することができ、また小じわの発
生、肌の「つや」や「はり」の喪失といった肌の老化現
象を防止・改善する効果をも有する。[Effects of the Invention] Since the skin cosmetic of the present invention has a remarkable sebum secretion promoting effect, it has an excellent skin roughness improving effect, an effect of reducing skin inflammation, etc., can be widely applied, and the occurrence of fine wrinkles, It also has the effect of preventing and improving skin aging phenomena, such as loss of skin gloss and stiffness.
フロントページの続き (56)参考文献 特開 平3−255015(JP,A) 特開 平3−188008(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 Continuation of the front page (56) References JP-A-3-255015 (JP, A) JP-A-3-188008 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A61K 7 / 00
Claims (1)
る皮膚化粧料。(1) A skin cosmetic comprising an extract of Akeboshi.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2073993A JP3000224B2 (en) | 1990-03-23 | 1990-03-23 | Skin cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2073993A JP3000224B2 (en) | 1990-03-23 | 1990-03-23 | Skin cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH03275609A JPH03275609A (en) | 1991-12-06 |
| JP3000224B2 true JP3000224B2 (en) | 2000-01-17 |
Family
ID=13534156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2073993A Expired - Fee Related JP3000224B2 (en) | 1990-03-23 | 1990-03-23 | Skin cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3000224B2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08283143A (en) * | 1995-04-14 | 1996-10-29 | Kose Corp | Topical skin |
| JP2000128728A (en) * | 1998-10-20 | 2000-05-09 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
| JP2008013461A (en) * | 2006-07-04 | 2008-01-24 | Geo Co Ltd | Antioxidant composition |
| JP6320034B2 (en) * | 2013-12-26 | 2018-05-09 | 日本メナード化粧品株式会社 | Sebum synthesis accelerator |
| CN104873437A (en) * | 2015-06-04 | 2015-09-02 | 贵阳医学院 | Fructus-rosae-laevigatae skin cream and preparation method thereof |
| CN109157447B (en) * | 2018-09-25 | 2021-10-26 | 任旻琼 | Application of cherokee rose fruit extract in whitening, moisturizing and anti-aging skin care product and preparation method thereof |
| CN115120543B (en) * | 2022-07-21 | 2023-11-10 | 菏泽市亿鑫生物科技有限公司 | Sophora japonica and saccharomycete fermentation liquor allergy-relieving composition and preparation and application thereof |
| CN115137688A (en) * | 2022-08-17 | 2022-10-04 | 广西和桂集团有限公司 | Preparation method of face wrinkle-removing whitening nursing composition |
-
1990
- 1990-03-23 JP JP2073993A patent/JP3000224B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03275609A (en) | 1991-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3112436B2 (en) | In particular, the use of honey as a keratolytic agent to improve the brightness of the skin facial and treat wrinkles | |
| JPS60202806A (en) | Whitening cosmetic | |
| JP3135943B2 (en) | Whitening agent | |
| JP2764510B2 (en) | Whitening cosmetics | |
| JP3000224B2 (en) | Skin cosmetics | |
| JPH0665044A (en) | Skin external preparation | |
| JPS60116618A (en) | Cosmetic | |
| JP2891727B2 (en) | Hair restoration | |
| JP2000109417A (en) | Cosmetic for improving somber color | |
| JP3104938B2 (en) | Cosmetics | |
| JP3101090B2 (en) | External preparation for skin | |
| JP2001131031A (en) | Composition for scalp and hair | |
| JPH11199463A (en) | Skin cosmetic | |
| DE60314987T2 (en) | A hair treatment composition containing a pyrimidine N-oxide derivative, its use for stimulating the growth of keratin fibers and / or for slowing their failure | |
| JP2938253B2 (en) | Hair growth and hair growth fees | |
| JP2000026269A (en) | Cosmetic | |
| JP2855274B2 (en) | Hair restoration | |
| JPH1017431A (en) | Skin ununiformity improver and cosmetic containing the same | |
| JP3382146B2 (en) | External preparation for skin | |
| JP2003342156A (en) | External preparation for skin for prevention of aging | |
| JPH08119829A (en) | Topical skin | |
| JP2001031554A (en) | External preparation for skin | |
| JPH10147514A (en) | Cosmetic | |
| JP2811479B2 (en) | Hair restoration | |
| JP2002234812A (en) | Cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071112 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091112 Year of fee payment: 10 |
|
| LAPS | Cancellation because of no payment of annual fees |